公开(公告)号：US09177347B2

公开(公告)日：2015-11-03

申请号：US13606001

申请日：2012-09-06

Applicant: Todd Christopher Jackson ,  William Russell Maschmeyer ,  Bin Jiang ,  Kenneth M. Lau ,  Michael Novati

Inventor： Todd Christopher Jackson ,  William Russell Maschmeyer ,  Bin Jiang ,  Kenneth M. Lau ,  Michael Novati

IPC: G06F15/16 ,  G06Q50/00 ,  H04L29/08

CPC classification number: G06Q50/01 ,  H04L67/22 ,  H04L67/306

Abstract: Based on information associated with users, a social networking system recommends one or more groups for a target user to join or to create. Characteristics of the target user, characteristics of users connected to the target user, characteristics of candidate groups in the social networking system may be used to identify groups for recommendation. The social networking system may provide questions to the target user and recommend a group to the target user based on received answers to the questions. For example, the answers to the provided question identify one or more characteristics of the target user, which are used to select a group for recommendation. Additionally, the social networking system may recommend additional users for the target user to add or invite to a group based on characteristics of the target user, the additional users, and/or the group.

Abstract translation: 基于与用户相关的信息，社交网络系统建议一个或多个组为目标用户加入或创建。 目标用户的特征，连接到目标用户的用户的特征，社交网络系统中的候选组的特征可以用于识别用于推荐的组。 社交网络系统可以向目标用户提供问题，并且基于接收到的问题答案向目标用户推荐组。 例如，提供的问题的答案识别目标用户的一个或多个特征，其用于选择用于推荐的组。 此外，社交网络系统可以基于目标用户，附加用户和/或组的特征来推荐目标用户的附加用户添加或邀请给组。

公开(公告)号：US08737347B2

公开(公告)日：2014-05-27

申请号：US13497150

申请日：2010-11-02

Applicant: Xiqi Gao ,  Bin Jiang ,  Xiaohu You ,  Teer Ba ,  Shi Jin ,  Jue Wang ,  Dongming Wang ,  Yanxiang Jiang

Inventor： Xiqi Gao ,  Bin Jiang ,  Xiaohu You ,  Teer Ba ,  Shi Jin ,  Jue Wang ,  Dongming Wang ,  Yanxiang Jiang

IPC: H04W72/04

CPC classification number: H04B7/0697 ,  H04J11/0033 ,  H04L25/0228

Abstract: A pilot and channel estimation method for SDMA MIMO transmission downlink is provided in the present invention, and the method provides possibility for saving the orthogonal pilot resources; the pilot signals of different users in the transmitting antenna domain can occupy the same time-frequency resources, and thereby the pilot overhead of system resources can be reduced greatly; the method includes: for the MIMO transmission downlink that employs pre-coding for SDMA, taking the quantity of orthogonal pilot resources occupied by the users in the pre-coding domain as the number of data streams that can be transmitted or the number of spatial dimensions occupied first, at the transmitting end of the base station; then, performing SDMA transmission pre-coding for the orthogonal pilots in the pre-coding domain in the same way as the data signals, to obtain the pilot signals of the users in the transmitting antenna domain; wherein, the pilots of the users in the pre-coding domain can be orthogonal in the frequency domain or code domain, and the pilots of different users in the pre-coding domain can be identical or not identical to each other; the pilot signals of different users in the transmitting antenna domain can occupy the same time-frequency resources.

Abstract translation: 本发明提供了一种用于SDMA MIMO传输下行链路的导频和信道估计方法，该方法提供了保存正交试验资源的可能性; 发射天线域中不同用户的导频信号可以占用相同的时频资源，从而大大降低系统资源的导频开销; 该方法包括：对于采用SDMA预编码的MIMO传输下行链路，将预编码域中的用户占用的正交导频资源的数量作为可以发送的数据流的数量或空间维数 首先占用基站的发射端; 然后以与数据信号相同的方式对预编码域中的正交导频执行SDMA传输预编码，以获得发射天线域中用户的导频信号; 其中，预编码域中的用户的导频可以在频域或码域中正交，并且预编码域中的不同用户的导频可以相同或不相同; 发射天线域中不同用户的导频信号可以占用相同的时频资源。

公开(公告)号：US20140011800A1

公开(公告)日：2014-01-09

申请号：US14005568

申请日：2012-03-16

Applicant: Stephen T. Wrobleski ,  Jagabandhu Das ,  JIngwu Duan ,  Junqing Guo ,  John Hynes ,  Bin Jiang ,  James Kempson ,  Shuqun Lin ,  Zhonghui Lu ,  William J. Pitts ,  Steven H. Spergel ,  Hong Hu ,  Bingwei Vera Yang

Inventor： Stephen T. Wrobleski ,  Jagabandhu Das ,  JIngwu Duan ,  Junqing Guo ,  John Hynes ,  Bin Jiang ,  James Kempson ,  Shuqun Lin ,  Zhonghui Lu ,  William J. Pitts ,  Steven H. Spergel ,  Hong Hu ,  Bingwei Vera Yang

IPC: C07D487/04

CPC classification number: C07D487/04 ,  C07D519/00

Abstract: The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.

Abstract translation: 本发明提供式I化合物及其药学上可接受的盐。 式I化合物抑制JAK3的酪氨酸激酶活性，从而使其可用于治疗炎症和自身免疫性疾病。

公开(公告)号：US20120121048A1

公开(公告)日：2012-05-17

申请号：US13387308

申请日：2010-11-02

Applicant: Xiqi Gao ,  Wenjin Wang ,  Ting Li ,  Meili Zhou ,  Bin Jiang ,  Wen Zhong ,  Long Qin

Inventor： Xiqi Gao ,  Wenjin Wang ,  Ting Li ,  Meili Zhou ,  Bin Jiang ,  Wen Zhong ,  Long Qin

IPC: H04L27/06

CPC classification number: H04L25/0204 ,  H04B7/0413 ,  H04L25/0232 ,  H04L27/2647

Abstract: A multi-antenna channel estimation method based on polyphase decomposition includes: receiving frequency domain received signals transformed using discrete fourier transformation (DFT) in pilot symbols; performing phase correction on the frequency domain received signals; performing polyphase decomposition on the frequency domain received signals which are corrected using phase correction and acquiring polyphase signals; performing interpolation on the polyphase signals and acquiring the estimation values of the multi-antenna channel parameters with various linear combinations on each frequency; acquiring decorrelation array based on the pilot structure of the transmission antenna and decorrelating the estimation values of the multi-antenna channel parameters with various linear combination on each frequency using the decorrelation array and acquiring channel parameters of the pilot symbols on each frequency; acquiring channel parameters of data symbols based on the channel parameters of the pilot symbols. With the present invention, the inversion problem in multi-antenna channel estimation is avoided with lower complexity, and results of the multi-antenna channel estimation method become more accurate since the DFT and filtering are performed in the interpolation after polyphase decomposition.

Abstract translation: 基于多相分解的多天线信道估计方法包括：在导频符号中接收使用离散傅立叶变换（DFT）变换的频域接收信号; 对频域接收信号进行相位校正; 对使用相位校正和获取多相信号校正的频域接收信号执行多相分解; 对所述多相信号执行插值，并且在每个频率上以各种线性组合获取所述多天线信道参数的估计值; 基于发射天线的导频结构获取解相关阵列，并使用解相关阵列在每个频率上用各种线性组合去除多个天线信道参数的估计值，并获取每个频率上的导频符号的信道参数; 基于导频符号的信道参数获取数据符号的信道参数。 利用本发明，以更低的复杂度避免了多天线信道估计中的反转问题，并且由于在多相分解之后的内插中执行DFT和滤波，所以多天线信道估计方法的结果变得更加精确。

公开(公告)号：US08034940B2

公开(公告)日：2011-10-11

申请号：US11835438

申请日：2007-08-08

Applicant: David S. Weinstein ,  Ping Chen ,  T. G. Murali Dhar ,  Jingwu Duan ,  Hua Gong ,  Bin Jiang ,  Bingwei Vera Yang ,  Arthur M. Doweyko

Inventor： David S. Weinstein ,  Ping Chen ,  T. G. Murali Dhar ,  Jingwu Duan ,  Hua Gong ,  Bin Jiang ,  Bingwei Vera Yang ,  Arthur M. Doweyko

IPC: C07D491/052 ,  A61K31/436

CPC classification number: C07D417/12 ,  C07D277/46 ,  C07D405/12 ,  C07D417/14 ,  C07D491/04

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity, including inflammatory and immune diseases, having the structure of formula (I): an enantiomer, diastereomer, or tautomer thereof, or a prodrug ester thereof, or a pharmaceutically-acceptable salt thereof, in which: Z is heterocyclo or heteroaryl; A is a 5- to 8-membered carbocyclic ring or a 5- to 8-membered heterocyclic ring; B is a cycloalkyl, cycloalkenyl, aryl, heterocyclo, or heteroaryl ring, wherein each ring is fused to the A ring on adjacent atoms and optionally substituted by one to four groups which are the same or different and are independently selected from R5, R6, R7, and R8; J1, J2, and J3 are at each occurrence the same or different and are independently -A1QA2-; Q is a bond, O, S, S(O), or S(O)2; A1 and A2 are the same or different and are at each occurrence independently selected from a bond, C1-3alkylene, substituted C1-3alkylene, C2-4alkenylene, and substituted C2-4alkenylene, provided that A1 and A2 are chosen so that ring A is a 5- to 8-membered carbocyclic or heterocyclic ring; R1 to R11 are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.

Abstract translation: 提供新的非甾体化合物，其可用于治疗与式（I）结构的糖皮质激素受体，AP-1和/或NF-κB活性（包括炎症和免疫疾病）的调节相关的疾病： 其对映异构体，非对映体或其互变异构体或其前药酯或其药学上可接受的盐，其中：Z是杂环或杂芳基; A是5至8元碳环或5至8元杂环; B是环烷基，环烯基，芳基，杂环基或杂芳基环，其中每个环与相邻原子上的A环稠合并任选地被一至四个相同或不同的基团取代，并且独立地选自R5，R6， R7和R8; J1，J2和J3各自出现相同或不同，独立地为-A1QA2-; Q是键，O，S，S（O）或S（O）2; A1和A2相同或不同，并且在每次出现时独立地选自键，C1-3亚烷基，取代的C1-3亚烷基，C2-4亚烯基和取代的C2-4亚烯基，条件是选择A1和A2使得环A为 5-至8-元碳环或杂环; R1至R11如本文所定义。 还提供了使用所述化合物治疗炎性或免疫相关疾病和肥胖症和糖尿病的药物组合物和方法。

公开(公告)号：US20110151094A1

公开(公告)日：2011-06-23

申请号：US13061051

申请日：2008-08-26

Applicant: Check Woo Foo ,  Stefan Kasapis ,  Lee Wah Koh ,  Bin Jiang

Inventor： Check Woo Foo ,  Stefan Kasapis ,  Lee Wah Koh ,  Bin Jiang

IPC: A21D2/18 ,  A23L1/16 ,  A21D13/00 ,  A23L1/05 ,  A23P1/08

CPC classification number: A23L29/256 ,  A23L7/109 ,  A23L7/113 ,  A23V2002/00 ,  A23V2200/328 ,  A23V2200/224 ,  A23V2250/1578 ,  A23V2250/50 ,  A23V2250/5026

Abstract: The present invention describes a method of reducing the enzymatic digestion rates of starch granules in food, particularly rice-based food. The method is carried out by encapsulating the starch granules with a reaction compound formed by the chemical reaction of at least a crosslinkable polysaccharide that has been pre-mixed with the ingredients for food production, and at least a crosslinking agent. The invention also relates to a process of preparing food products by incorporating the method of the present invention and food products produced by the present method.

Abstract translation: 本发明描述了一种降低食品中淀粉颗粒的酶消化速率的方法，特别是基于米的食品。 该方法通过将淀粉颗粒与通过与预先用于食品生产的成分进行预混合的至少可交联多糖的化学反应形成的反应化合物和至少一种交联剂进行包封来进行。 本发明还涉及通过掺入本发明的方法和通过本方法生产的食品来制备食品的方法。

公开(公告)号：US07902870B1

公开(公告)日：2011-03-08

申请号：US12470943

申请日：2009-05-22

Applicant: Bin Jiang

Inventor： Bin Jiang

IPC: H03L5/00 ,  H03K19/0175

CPC classification number: H03K19/01714 ,  H03K19/018514

Abstract: A level shifter circuit for shifting from a first voltage level technology (such as 0.9 volt) to a second level voltage technology (such as 3.3 volt) with increased switching speed. The increased speed is achieved by adding a boost circuit to the pull-up transistors to boost the switching speed and shut itself down after the transition. The level shifter circuit does not require intermediate level transistors or intermediate level voltage sources.

Abstract translation: 一种用于从第一电压电平技术（例如0.9伏特）转换到具有增加的切换速度的第二电平电压技术（例如3.3伏特）的电平移位器电路。 通过向上拉晶体管添加升压电路以提高开关速度并在转换后关闭自身来实现增加的速度。 电平移位器电路不需要中间级晶体管或中间电平电压源。

公开(公告)号：US07888381B2

公开(公告)日：2011-02-15

申请号：US11451660

申请日：2006-06-13

Applicant: Jingwu Duan ,  Zhonghui Lu ,  David S. Weinstein ,  Bin Jiang

Inventor： Jingwu Duan ,  Zhonghui Lu ,  David S. Weinstein ,  Bin Jiang

IPC: C07D231/56 ,  A01N43/56

CPC classification number: C07D401/04 ,  C07D231/56 ,  C07D401/06 ,  C07D403/04 ,  C07D405/04 ,  C07D405/06 ,  C07D409/06 ,  C07D417/06 ,  C07D417/12

Abstract: Non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or an enantiomer, a diastereomer, a pharmaceutically acceptable salt, or hydrate thereof, where J is selected from NR1 or C(R4)(R4a); K is selected from NR2 or C(R5)(R5a); L is selected from NR3 or C(R6)(R6a); and A, X, Y, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R8, R10, R11, and n are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Abstract translation: 提供非甾体化合物，其可用于治疗与调节糖皮质激素受体，AP-1和/或NF-κB活性相关的疾病，包括肥胖症，糖尿病，炎症和免疫疾病，并且具有式 I）或其对映异构体，非对映异构体，药学上可接受的盐或水合物，其中J选自NR 1或C（R 4）（R 4a）; K选自NR2或C（R5）（R5a）; L选自NR 3或C（R 6）（R 6a）; 并且A，X，Y，R 1，R 2，R 3，R 4，R 4a，R 5，R 5a，R 6，R 6a，R 8，R 10，R 11和n如本文所定义。 还提供了治疗肥胖症，糖尿病和包含所述化合物的炎性或免疫相关疾病的药物组合物和方法。

公开(公告)号：US07719314B1

公开(公告)日：2010-05-18

申请号：US12546237

申请日：2009-08-24

Applicant: Bin Jiang ,  Sang Kong Chan

Inventor： Bin Jiang ,  Sang Kong Chan

IPC: H03K19/0175 ,  H03K3/00

CPC classification number: H03K5/01 ,  H03K5/06

Abstract: An interface driver circuit includes a plurality of delay cells. Each delay cell includes a data input, a delayed data output configured to communicate with the data input of an adjacent one of the plurality of delay cells. A delay time input is configured to set a delay value between receiving data at the data input and generating the delayed data output. A plurality of predrivers is configured to receive an output enable signal. A plurality of predrivers is configured to receive a corresponding one of the plurality of delayed data outputs. A plurality of predrivers is configured to generate a predriver output signal based on the output enable signal and the corresponding one of the plurality of delayed data outputs. The output enable signal enables and disables the plurality of predrivers and is independent of data of each delayed data output.

Abstract translation: 接口驱动电路包括多个延迟单元。 每个延迟单元包括数据输入端，被配置为与多个延迟单元中相邻的延迟单元的数据输入通信的延迟数据输出。 延迟时间输入被配置为在数据输入端接收数据和产生延迟的数据输出之间设置延迟值。 多个预驱动器被配置为接收输出使能信号。 多个预驱动器被配置为接收多个延迟数据输出中的对应的一个。 多个预驱动器被配置为基于所述输出使能信号和所述多个延迟数据输出中的相应一个来产生预驱动输出信号。 输出使能信号启用和禁用多个预驱动器，并且独立于每个延迟的数据输出的数据。

公开(公告)号：USD603373S1

公开(公告)日：2009-11-03

申请号：US29330563

申请日：2009-01-09

Applicant: Bin Jiang

Designer： Bin Jiang